↓ Skip to main content

American Association for Cancer Research

Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

Overview of attention for article published in Cancer Research, March 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
9 news outlets
twitter
25 X users
facebook
1 Facebook page

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
41 Mendeley
Title
Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
Published in
Cancer Research, March 2022
DOI 10.1158/0008-5472.can-21-1843
Pubmed ID
Authors

Katrina M. Lappin, Eliana M. Barros, Satpal S. Jhujh, Gareth W. Irwin, Hayley McMillan, Fabio G. Liberante, Cheryl Latimer, Melissa J. La Bonte, Ken I. Mills, D. Paul Harkin, Grant S. Stewart, Kienan I. Savage

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 20%
Student > Ph. D. Student 8 20%
Student > Master 3 7%
Lecturer 1 2%
Unspecified 1 2%
Other 3 7%
Unknown 17 41%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 29%
Medicine and Dentistry 6 15%
Agricultural and Biological Sciences 3 7%
Mathematics 1 2%
Unspecified 1 2%
Other 2 5%
Unknown 16 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 83. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2022.
All research outputs
#509,955
of 25,304,569 outputs
Outputs from Cancer Research
#281
of 19,102 outputs
Outputs of similar age
#13,627
of 437,924 outputs
Outputs of similar age from Cancer Research
#11
of 190 outputs
Altmetric has tracked 25,304,569 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,102 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,924 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 190 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.